[EN] DISUBSTITUTED CYCLOPENTANE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE DE CYCLOPENTANE DISUBSTITUÉS
申请人:ANRUI BIOMEDICAL TECH GUANGZHOU CO LTD
公开号:WO2022135365A1
公开(公告)日:2022-06-30
Provided herein are novel compounds (e.g., Formula I or II), pharmaceutical compositions, and methods of using related to cyclin dependent kinases (CDKs). The compounds herein are typically CDK2 inhibitors, which can be used for treating a variety of diseases or disorders, such as cancer.
本文提供了一些新颖的化合物(例如,公式I或II),药物组合物和使用方法,与细胞周期依赖性激酶(CDKs)有关。这些化合物通常是CDK2抑制剂,可用于治疗各种疾病或疾病,如癌症。